What's Ahead In The US Senate: Support Builds For Bills To Lower Health-Care Costs, End Device Tax
Executive Summary
The medtech industry should expect legislation to gain attention in the US Senate in the coming months to lower health-care costs and promote transparency to allow cost-conscious patients to shop for the most effective and lowest-priced surgical and advanced imaging procedures, as well as bills to repeal the device tax, key Senate health players say.
You may also be interested in...
US House Preview: Health Panels To Push Device Tax Repeal, Shutdown Contingency Bills In 2019
US House lawmakers might pursue legislation in 2019 to repeal the device tax, ensure that FDA can continue working on medtech product reviews during US government shutdowns, and to stabilize the Affordable Care Act to lower health-care costs for patients.
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
Industry's top leaders weren't exactly eager to testify on Capitol Hill. Now they might be wondering why they waited so long. Seven pharma leaders avoided missteps during a Senate Finance Committee hearing on drug pricing Feb. 26.
New Device Tax Repeal Bills Are Coming, With Candidate Klobuchar's Help
Despite a recent report that Sen. Amy Klobuchar, D-Minn., is backing away from leading efforts to repeal the medical device tax due to her presidential ambitions, sources say she is working with Sen. Pat Toomey, R-Pa., to cosponsor a repeal bill this year. Similarly, on the US House-side, Rep. Ron Kind, D-Wisc., is calling on his colleagues to support a full repeal bill as well.